$2.28
N/A
At close: May 11, 5:00 PM EST
$2.30
0.01960.86%
After Hours: 4:22 PM EST
Allogene Therapeutics Inc Earnings Estimates
ALLONASDAQ
Earnings: Q1 2026 earnings tomorrow on Wed May 13th after the market close
Allogene Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ALLO
Allogene Therapeutics (ALLO) is scheduled to report Q1 earnings on May 13, 2026. Analysts estimate EPS of $-0.18 and quarterly revenue of $1.82K.
In the most recent quarter (Q4), Allogene Therapeutics reported EPS of $-0.17, beating estimates of $-0.23 by 0.26%. Revenue came in at $0.00, missing the estimate of $2.00K by 1.00%.
Allogene Therapeutics has beaten EPS estimates in 6 consecutive quarters.
Over the last 4 quarters, Allogene Therapeutics has averaged an EPS surprise of 0.15% and a revenue surprise of 1.00%.
Earnings Date
May 13
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$1.82K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Allogene Therapeutics Earnings History
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Loading calendar...
Allogene Therapeutics (ALLO) Earnings Per Share
The chart below shows Allogene Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Allogene Therapeutics (ALLO) Revenue
The chart below shows Allogene Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics (ALLO) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on March 12, 2026 for Q4.
What were the latest earnings per share (EPS) for Allogene Therapeutics (NASDAQ:ALLO)?
The Actual EPS was $-0.17, which beat the estimate of $-0.23.
What were Allogene Therapeutics’s (NASDAQ:ALLO) revenues?
The Actual Revenue was $0.00, which missed the estimate of $2.00K.
